Hanmi Group Affiliate Delegation Urges "Stop the Disputes" Over Hanmi Pharm's Independent Management, Citing "Increased Confusion"
"Refusal of Wrongful Management Interference by Some Shareholders and External Forces"
A delegation of representatives from Hanmi Group affiliates issued a statement criticizing Hanmi Pharm's move toward independent management.
According to Hanmi Science on the 4th, the heads of major affiliates excluding Hanmi Pharm?Im Haeryong, General Manager of Beijing Hanmi Pharm; Jang Younggil, CEO of Hanmi Fine Chemical; Woo Gisuk, CEO of Online Pharm; Lee Donghwan, CEO of JVM; and Park Junseok, Vice President of Healthcare Business Division at Hanmi Science?jointly released this statement on Hanmi Group's internal network.
They claimed that "external forces have intervened in the inheritance tax issues that the major shareholder family should bear," and described the independent management as "an act that exacerbates confusion."
They added, "The major shareholder family should unite and cease all disputes for the future of Hanmi," and "We reject the wrongful management interference by some shareholders and external forces."
Earlier, Hanmi Pharm had begun to actively pursue independent management centered on professional CEO Park Jaehyun in August, implementing organizational restructuring such as establishing HR and Legal teams. The Hanmi Pharm Group is currently divided between the 'brother faction'?Im Jongyoon, inside director of Hanmi Science holding the holding company's management rights, and his brother Im Jonghun, CEO?and the 'three-party alliance'?their mother Song Youngsook, Chairwoman of Hanmi Pharm Group; their sister Im Juhyun, Vice Chairwoman; and Shin Dongguk, Chairman of Hanyang Precision and the largest individual shareholder?who advocate for introducing a professional management system and demand a reorganization of the holding company's board of directors.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Despite Warnings of "Do Not Enter, You May Not Make It Out Alive"... Foreign Tourist Stranded After Unauthorized Climb on Jeju Sanbangsan
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The brother faction and the three-party alliance will compete in a vote over the board size and other matters at the Hanmi Science extraordinary shareholders' meeting scheduled for the 28th. On the 19th of next month, an extraordinary shareholders' meeting of Hanmi Pharm will be held to address agenda items including the dismissal of CEO Park.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
